# FDA 483 - Kendrick Laboratories - March 10, 2020

Source: https://www.globalkeysolutions.net/records/483/kendrick-laboratories/55b12559-39e3-43ab-93df-871a292e238e

> FDA 483 for Kendrick Laboratories on March 10, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kendrick Laboratories
- Inspection Date: 2020-03-10
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Kendrick Laboratories, a contract testing laboratory in Madison, WI, revealed two significant observations. The firm lacked adequate laboratory controls to ensure the originality of paper documents and proper management of GMP data. Additionally, a senior biochemist was found to lack documented training for specific sample preparation procedures.

## Related Officers

- [Lori B. Wikstrom](https://www.globalkeysolutions.net/people/lori-b-wikstrom/19d938f7-4a5d-42b9-b2d1-e92cdb63bb0d)
- [Drug National Expert](https://www.globalkeysolutions.net/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)

Company: https://www.globalkeysolutions.net/companies/kendrick-laboratories/dcbc2167-1dc5-40d5-92b6-502718e513f0

Office: https://www.globalkeysolutions.net/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d